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The mammalian retina contains at least two guanylyl 
cyclases (GC1 and GC2) and two guanylyl cyclase-acti­
vating proteins (GCAPl and GCAP2). Here we present 
evidence of the presence of a new photoreceptor-spe­
cific GCAP, termed GCAP3, which is closely related to 
GCAPl. The sequence similarity of GCAP3 with GCAPl 
and GCAP2 is 57 and 49%, respectively. Recombinant 
GCAP3 and GCAP2 stimulate GC1 and GC2 in low 
[Ca2+]frco and inhibit GCs when [Ca2+]froo is elevated, 
unlike GCAPl, which only stimulates GC1. GCAP3 is 
encoded by a distinct gene present in other mammalian 
species but could not be detected by genomic Southern 
blotting in rodents, amphibians, and lower vertebrates. 
The intron/exon arrangement of the GCAP3 gene is iden­
tical to that of the other GCAP genes. While the GCAPl 
and GCAP2 genes are arranged in a tail-to-tail array on 
chromosome 6p in human, the GCAP3 gene is located on 
3ql3.1, suggesting an ancestral gene duplication/trans­
location event. The identification of multiple Ca2+-bind- 
ing proteins that interact with GC is suggestive of com­
plex regulatory mechanisms for photoreceptor GC.
Absorption of light by rhodopsin results in a decrease of 
[cGMP] w ithin photoreceptor outer segments (1). This leads to 
the closure of cGMP-gated cation channels and reduction in 
Ca2+ influx (reviewed in Refs. 2 and 3). In addition, Ca2+ is 
continuously extruded from the photoreceptor cells by a light- 
independent N a+/Ca2+-K+ exchanger (4). The net resu lt of 
photoactivation is a  decrease in intracellu lar [cGMP] and 
[Ca2+], Guanylyl cyclase-activating proteins (GCAPs)1 are ac­
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1 The abbreviations used are: GCAP, guanylyl cyclase-activating pro-
tivated by th is decrease in  [Ca2+] and accelerate cGMP produc­
tion by stim ulating GCs. Increase in [cGMP] leads to the open­
ing of the cation channels and restores the dark  conditions of 
photoreceptors (5). Two GCAPs have been identified in  photo­
receptors, GCAPl (6) and GCAP2 (7, 8), as well as two guanylyl 
cyclases, GC1 (9, 10) and GC2 (11). GCAPl exclusively stim u­
lates GC1, while GCAP2 stim ulates both GC1 and GC2 (12). 
Recently, a th ird  GCAP-like photoreceptor protein, guanylyl 
cyclase-inhibitory protein, term ed GC1P, was identified in frog 
cone photoreceptors and also was shown to in teract w ith GC 
(13).
GCAPs are Ca2+-binding proteins belonging to the calmod­
ulin superfam ily but they only have three functional EF-hand 
motifs. GCAPl and GCAP2 genes are organized in  a tail-to-tail 
array  in  vertebrates (14^16). In  hum ans, the array  is located 
on the short arm  of chromosome 6 (p21.1). A defect in the 
GCAPl gene (Y99C) has recently been linked to autosomal 
dom inant cone dystrophy (17-19), which affects cones but not 
rods. The Y99C m utation has been shown to a lter Ca2+ sensi­
tivity of GCAPl, leading to the constitutive stim ulating activity 
of GC1 a t high [Ca2+], where normal GCAPl inhibits it. 
GCAPl has been localized to rod and cone photoreceptor outer 
segments in the re tina  of various species (8, 15, 20, 21), while 
GCAP2 has been detected in cone inner segments (22), rods (7), 
and the inner re tina  (15, 21). GCAPl has been proposed to be 
a major regulator of GC in the preparations of bovine rod outer 
segments (ROS) (6, 8). In hum ans, the most intense labeling 
with anti-GCAPl antibodies has been observed in cone outer 
segments, and w eaker labeling has been observed in rod outer 
segments (8, 21). Since hum an rods are unaffected in autoso­
mal dom inant cone dystrophy, GCAP2 or a th ird  GCAP-like 
Ca2+-binding protein m ay substitu te in p art for the m utan t 
GCAPl, or rods are less sensitive to elevated cGMP levels (18). 
In th is paper, we describe molecular cloning and characteriza­
tion of a  th ird  form of GCAP, GCAP3, which by sequence 
sim ilarity appears to be more closely related to GCAPl than  to 
GCAP2. This novel isoform provides additional evidence of 
complex regulations of cGMP production/degradation in  photo­
receptor cells from different species and of the existence of an 
evolving family of GCAP genes.
MATERIALS AND METHODS
cDNA Cloning o f  GCAP3^GCAP3 was amplified from a AgtlO h u ­
m an re tina  cDNA library in two overlapping fragm ents using prim ers 
designed based on the  expressed sequence tag  clone (a364442 deposited 
A. R. Kerlavage, The Institu te  for Genomic Research, Rockville, MD).
tein; GC, guanylyl cyclase; PCR, polymerase chain reaction; PBS, phos­
phate-buffered saline; BAC, bacterial artificial chromosome; kb, kilo- 
base(s); FISH, fluorescence in situ  hybridization; ROS, rod outer 
segment(s).






















F ig. 1. A lig n m en t o f  G CA Ps w ith  re c o v e r in  a n d  c a lm o d u lin . 1, hum an GCAP3; 2, hum an GCAPl (34,); 3, hum an GCAP2 (14,); 4, frog 
guanylyl cyclase-inhibitoiy protein (13,); 5, hum an recoverin (35,); 6, hum an calmodulin (36,) amino acid sequences. Top left, dendrogram  generated 
by PC/Gene (Intelligenetics. Inc.,) based on amino acid sequence sim ilarity. The numbers inside the dendrogram  reflect percentage identities with 
GCAP3 as 100%. Shaded areas denote EF-hand motifs. Amino acid residues conserved in  all six sequences are printed white on black. Amino acids 
common to GCAP2 and GCAP3. but distinct from GCAPl. are boxed.
F ig. 2. T is su e  d is t r ib u t io n  o f
GCAP3 m R N A  A. a N orthern blot con­
taining 2 /iig of poly(A,) RNA from hum an 
re tina  and from various hum an tissues 
was probed with 32P-labeled GCAP3 
cDNA or with a control 32P-labeled glyc- 
eraldehyde-3-phosphate dehydrogenase 
probe. B. a N orthern blot containing 2 /iig 
of poly(A,) RNA from hum an and bovine 
re tina  was probed with 32P-labeled 
GCAPl. GCAP2. or GCAP3 cDNA. The 
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The 3'-end was amplified with primers K3 (5'-TGT GAG TCA AGA 
TGG GGA ATG GCA. gene-specific primer,) and AgtlOS (5'-AGC AAG 
TTC AGC CTG GTA AG,). After heating a t 95 °C for 5 min. the  reaction 
was cycled 35 tim es through 94 °C for 30 s. 68 °C for 2 min. A secondary 
nested PCR amplification was carried out w ith prim ers K4 (5'-GGC 
AAA TCT ATA GCT GGT GAT CAGA,) and AgtlOS as described above. 
The 5'-end was amplified following the same PCR conditions with 
primers K6 (5'-GGC CTT CTG ATT CAG ACC TTG CAG. gene-specific 
primer,) and AgtlOS. At least two amplification products for each PCR 
were subcloned into pCRll-TOPO vector (TOPO TA Cloning Kit. In­
vitrogen,) and sequenced by dyedeoxyterminator sequencing (AB1- 
Prism. Perkin-Elmer,).
Northern Blot Analysis—Total RNA was isolated from hum an retinal 
tissue, obtained from The Wisconsin Eye Bank a t the University of 
Wisconsin, or from bovine re tinas (Schenk Packing Co.. Inc. Stanwood. 
WA,) using the Ultraspec RNA isolation system (Biotecx. Inc.,). mRNA 
was purified from total RNA using the mRNA purification k it (Amer­
sham  Pharm acia Biotech,), resolved by agarose gel electrophoresis in 
the presence of 0.66 M formaldehyde, and transferred to nylon mem­
branes. Hybridization with a 32P-labeled hum an GCAP3 cDNA (1 kb,) 
was performed in  40% formamide. 10% dextran sulfate. 1% SDS. 1 M 
NaCl. 35 /ng/ml of herring sperm DNA in 50 m M  Tris. pH 7.4. Hybrid­
izations were washed a t room tem perature in 0.3 M NaCl. 0.03 M sodium 


































Q E T H V W Y R T F M M E Y P S G L Q T
6441--------------------------------►
TACATGAATTTAAGACACTTTTGGGTCTGCAAGGTCTGAATCAGAAGGCCAATAAACATA 
L H E F K T L L  ^ L Q G L N Q f e c A N K H
TTGAT^AAGTTTATAATACCTTTGAck^^^ACAAGg taagatctttcatttttcatttca 



























D G F I D F L E F I A A V N L
AATCAT<^AAGAAAAAATGGAGCAAAAATTAAAATGGTATTTTAAGCTGTATGATGCTGA 
I M Q E K M E Q K L K W Y F K L Y D A D
TGG dj?&*?GGTTCT ATTG AC AAAAATG AACTACTGG AC ATGTTC ATGg taagtgaagtagt 




















A V Q A L N G Q Q T L S P E
GAATTCATCAA?ITGGTGTTCCATAAGATCG^rSTAAACAATGATGgtaatggagctact 
E F I N L V F H K I D I N N D g n g a t
ctctactggatcacttttcctacaaa^taggagatggtggtagtggggagtgttatttag 

















p p 4 tagacaaagcctcttattaactgtttattattttccagGGGAATTGACTTTAGAAGAATT
G E L  T L E E F 
g i Id f r r il
TATCAATGGCATGGCAAAAGATCAGGATCTCCTGGAGATTGTTTACAAGAGCTTCGACTT 














ly q w h g k
:^AATGTGCTGAGAGTAATCTGTAA^§ GAAGCAGCCAGACATGGAGACAGACTCCTC 
V L R V I C N G K Q P D M E T D S S
CTC1 











K S  P D K A G L G K V K M K
i m  iCTGTGAGAATACCT
F ig. 3. P a r t ia l  g e n e  se q u e n ce , e x o n /in tro n  ju n c t io n s  o f h u m a n  GCA Ps, a n d  ch ro m o so m a l lo c a liz a tio n  o f  h u m a n  GCAP3. A, gene 
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g g a t t a t c c a t t g g a a a g t g t c t c c a c a g t t t a g c a t t t t t a g Kt t a a a c a t c c a t g t g g
TAAATGTGCTTGCTGCCTCTTTGCTCCTGTTGCATCTGTTTA'flTATAAAtGACTGAG
B







T N K 
xl TTCAACAAGgtgagcagg..
F N K 
xl AAGAATGGGgtaaggcac.. 







D  N T
x2 ATGTTCATGgtaagtgaa..
M. F M 
x2 ATCATCCAGgtgcagagg..I I Q 
x2 ATTGTGGAGgttagtgtc..
I V  E 
xl ATCGTCATGgtcagtctc..
I V  M
x3 AACAATGATGgtaatggag.
N N D 
x3 AACGGGGATGgtgaggggg.
N G D 
x3 AATGGAGATGgtaagaggg.




A V Q 
.ccctcccagGCCATTCGC 
A I R  
.cttttgcagGGAATTTAC 
G I Y 
.ttggtacagGCTATTTTC 
A I F








hGCAP3 a = >10 kb
hGCAPl a = 4 . 5 kb
hGCAP2 a = 6 kb 
hRec
hOCAP3 b = 6 kb
hGCAPl b - 520 bp
hGCAP2 b - 4 kb
hRec a = 3.5 kb
hGCAP3 c - 8 kb
hGCAPl C - 347 bp
hGCAP2 c - 715 bp
hReo b - 3 kb
Ftg. 3—continued
NaCl, 0.0015 M sodium citrate, and 0.1% SDS. A hum an multiple-tissue 
Northern blot containing 2 /ng of poly(A)* RNA from various hum an 
tissues (CLONTECH Laboratories, Inc.) was hybridized with the  32P- 
labeled GCAP3 or glyceraldehyde-3-phosphate dehydrogenase cDNA 
according to the  m anufacturer’s instructions.
Expression o f GCAP3 in Insect Cells—The full coding sequence for 
GCAP3 was amplified from hum an retina cDNA by PCR with primers 
K9 (5'-CAT ATG GGG AAT GGC AAA TCT ATA GCTG), which placed 
an N de I site on the  ATG, and K10 (5'-CTA GTG ATG GTG ATG GTG 
ATG CTT CAT TTT CAC CTT CCC TAG ACC AG), which added a His6 
tag  a t the  3'-end. PCR was performed using a denaturing tem perature 
of 94 °C for 30 s and an annealing and extension tem perature of 68 °C 
for 2 min through 35 cycles. The PCR product was cloned in pCRII- 
TOPO vector (TOPO TA Cloning Kit, Invitrogen) and sequenced by 
dyedeoxyterminator sequencing (ABI-Prism, Perkin-Elmer). An X b a l-  
ffm d lll fragm ent was inserted between corresponding sites of the 
pFastBael expression vector (Life Technologies, Inc.). Sf9 insect cells 
were transfected with the  recombinant baculovirus shu ttle  vector using 
cationic liposome-mediated transfection (CellFECTIN reagent; Life 
Technologies) according to the m anufacturer’s protocol.
Expression o f GCAP3 in Escherichia coli—The coding sequence for 
GCAP3 was amplified from hum an retina cDNA by PCR with primers 
K9 (5'-CAT ATG GGG AAT GGC AAA TCT ATA GCTG), which placed 
an Nde  I site on the  ATG, and K20 (5'-CTA CTT CAT TTT CAC CTT 
CCC TAGA), using a denaturing tem perature of 94 °C for 30 s and an 
annealing and extension tem perature of 68 °C for 2 min through 35 
cycles. The PCR product was cloned in pCRII-TOPO vector and se­
quenced by dyedeoxyterminator sequencing. GCAP3 was inserted as a 
fragm ent N d e l-B a m HI in pET-3b vector (Novagen). GCAP3 was ex­
pressed in BL21 bacteria after induction with 0.2 mM isopropyl-1-thio- 
P-n-galactopyranoside. The bacteria were sonicated for 5 min in water, 
and the  extract was centrifuged a t 80,000 x  g  for 20 min. The pellet 
containing the inclusion bodies was solubilized in 8 M urea, 80 mM 
£>-mereaptoethanol and incubated for 90 min a t room tem perature. The
insoluble m aterial was centrifuged for 60 min a t 340,000 x  g .  The 
supernatan t was dialyzed against water.
Preparation o f Anti-GCAP3 Antibodies—Rabbit anti-GCAP3 poly­
clonal antibodies (UW84) were raised in New Zealand W hite rabbits by 
subcutaneous immunization with 100 /xg of GCAP3 expressed in E. coli 
mixed with an equal volume of complete Freund’s adjuvant (Cocalico 
Biologieals, Reanstown, PA). Animals were given booster injections a t 
1 2-week intervals with 50 /ng of GCAP3 mixed with incomplete 
Freund’s adjuvant. UW14 (anti-GCAPl) and UW50 (anti-GCAP2) were 
prepared following the  same procedure (8, 23).
Purification ofUW 14, UW50, UWS4, and UWS7—For UW50, 2 ml of 
rabbit serum  UW50 diluted 1:1 in 10 mM l,3-bis[tris(hydroxymethyl)- 
methylaminojpropane, pH 7.5, containing 50 mM NaCl, were depleted of 
antibodies cross-reacting with GCAPl by filtering through a GCAP1- 
Sepharose column (1.5 ml; 8 mg of protein/ml of CNBr-activated Sepha- 
rose 4B). The flow-through was then applied on a GCAP3-Sepharose 
(1.5 ml; 8 mg of protein/ml of CNBr-activated Sepharose 4B) to remove 
GCAP3 cross-reacting antibodies. The anti-GCAP2 antibodies present 
in the flow-through were finally purified on GCAP2-Sepharose (1.5 ml; 
8 mg of protein/ml of CNBr-activated Sepharose 4B) and eluted with 0.1 
M glycine, pH 2.5. For UW14, rabbit serum  UW14 was depleted of 
cross-reacting antibodies by passing through GCAP2 and GCAP3 col­
umns and then purified on GCAPl-Sepharose. For UW84, the flow­
through of successive GCAPl and GCAP2 columns loaded with rabbit 
serum  UW84 was purified on GCAP3-Sepharose. UW87 antiserum  was 
prepared against a 20-amino acid peptide, amide-CETDSSKSPDKA- 
GLGKVKMK prepared by Q uality Controlled Biochemicals Inc., conju­
gated to keyhole lim pet hemoeyanin. The sequence is derived from the 
C-terminal region unique to GCAP3. The peptide also contains the 
N-term inal Cys to facilitate conjugation to keyhole lim pet hemoeyanin 
and CNBr-activated Sepharose. UW87 antiserum  was purified on 
GCAP3-Sepharose.
Enzyme-linked Immunosorbent Assay—M icrotitration plates were 
coated for 1 h a t 37 °C with purified GCAPl or GCAP2 a t about 0.8
amplification of exons and introns are indicated by arrows pointing to the  left (antisense) or to the right (sense). The predicted amino acid sequences 
of the  exons are shown in single letter code, and the  residues are numbered on the  right. Capital letters denote the  normal GCAP3 sequence, and 
lowercase letters show the  predicted sequence of the  splice varian t 13b. The amino acid sequence of the  splice v arian t is numbered  on the  right in 
parentheses. The putative area of sequence sim ilarity to hum an ealbindin is boxed. The alternative splice site in intron c is marked by a triangle. 
Potential polyadenylation sites (37) in the  3 '-untranslated  region are boxed. The beginning and end of the  13b DNA sequence are identified by 
arrows. Functional EF-hand consensus sequences for Ca2* binding are shaded. B, schematic diagram  of the gene structure  th a t is identical for all 
known GCAPs. C, intron/exon junctions of GCAPl to -3 and recoverin. The approxim ate lengths of the  introns are given in the fa r right column, 
bp, base pairs. D, fluorescence in situ  hybridization of a GCAP3 cDNA probe to hum an chromosomes. The arrow  identifies the  location of the 

























fig/well. After coating, plates were blocked with PBS, 3% bovine serum 
album in for 1 h  a t room tem perature. After washing with PBS, 0.05% 
Tween, anti-GCAPl (UW14J, anti-GCAP2 (UW50J, or anti-GCAP3 
(UW84J, antibodies (0.45 fig) were added to the  plates w ith increasing 
am ounts of competitors (GCAPl, GCAP2, and GCAP3J for 1 h  a t room 
tem perature. After washing w ith PBS, 0.05% Tween, the  plates were 
incubated w ith alkaline phosphatase-conjugated goat anti-rabbit IgG 
(Promega) for 30 m in a t room tem perature. The plates were read a t 405 
nm after the addition of p-nitrophenvl phosphate.
GC Assays—The GC assays were'perform ed using [o-32PlGTP and 
washed ROS or using recom binant GC1 and GC2 as described previ­
ously (23J. GCAPl and GCAP3 proteins used in the GC assays were 
purified from insect cells on Ni2 1 -nitrilotriacetic acid columns in non­
denaturing  conditions according to the  m anufacturer’s protocol (Qia­
gen,). [Ca2 11,,.,,,, was adjusted bv EGTA/Ca buffer as described previously 
(8,). Bovine GC1 (obtained from Dr. R. SharmaJ and hum an GC2 (ob­
tained from Dr. A. Dizhoor) were cloned into pVL941 and expressed in 
High Five insect cells as described previously (8). The cells were h a r­
vested; washed w ith 10 m M  l,3-bis[tris(hydroxymethyl,)-methylamin- 
olpropane, pH 7.5, containing 100 m M  NaCl, and resuspended a t -0 .5  
mg/ml for the  GC assays.
The results of GC assays are an  average of two determinations. 
Sim ilar results were obtained from a t least three  different sets of 
experiments performed in  duplicate. Due to the high sensitivity of the 
GC system (for details, see Ref. 8), the  absolute values of one series 
occasionally varied from another by 10-20%, but w ith preservation of 
the ratio between activity of two different preparations (for example, 
the activity of GCAPl versus GCAP3J. Because only a  lim ited num ber of 
the test samples could be performed in a  single assay (maximally 24 
samples) th a t always included a  relevant control (low, high [Ca2 11 
and w ith or w ithout GCAPl,), the  results are shown without S.D. val­
ues. The IC50 and EC50 with S.D. were calculated from these independ­
ent experiments.
Southern Blotting—Genomic Southern blots containing & oRI-di- 
gested DNA from various species were purchased from BIOS laborato­
ries (New Haven, CT,). The blots were probed with 32P-labeled hum an 
GCAP3 cDNA insert. The hybridization and washing procedures were 
performed according to the  m anufacturer’s protocol. Briefly, hybridiza­
tion was carried out overnight w ith 107 cpm/ml of labeled GCAP3 cDNA 
a t 65 °C in 6 x  SSC (0.9 M  NaCl, 0.09 M sodium citrate), 1% SDS, 5x  
D enhardt’s solution (0.1% polyvinylpyrrolidone, 0.1 % Ficoll, 0.1% bo­
vine serum  albumin,), 200 fig/ml sheared, denatured salmon sperm 
DNA, and 10% dextran sulfate. The washing solution contained l x  SSC 
(0.15 M  sodium chloride, 0.015 M  sodium citrate,), 0.5% SDS and was 
performed a t room tem perature and a t 35 °C for 10 m in each. The blots 
were finally exposed to Kodak XAR5 film in the presence of intensifying 
screens.
Gene Characterization—A bacterial artificial chromosome (BAC) 
clone containing the  entire GCAP3 gene was purchased from Genome
Systems, Inc. BAC DNA was prepared using the  Qiagen method for low 
copy plasmids (Qiagen,). Introns b and c of the  GCAP3 gene were 
amplified w ith exon-specific prim ers from hum an genomic DNA with 
Taq (Promega,) or Expand  (Boehringer Mannheim,) DNA polymerases. 
Amplified introns were cloned into pCR2.1 vector and sequenced with 
universal prim ers using a model LI-COR 4000L autom atic DNA se­
quencer. The junctions of intron a were directly sequenced from the 
BAC clone using fluorescent chain term inators and an  ABI autom atic 
sequencer. PCR was performed with 2 ,xg  of BAC DNA, and 20 pmol of 
primer. The cycle conditions (MJ cycler, MJ Research,) were 95 °C for 5 
min (96 °C for 20 s, cooling a t 1 °C/s to 50 °C, 50 °C for 15 s, heating  a t
1 °C/s to 60 °C, 60 °C for 4 min,). The cycle shown in parentheses was 
repeated 49 times. The length of in tron  a was estim ated from A’coRI- 
digested fragm ents of the  BAC clone, probed after Southern blotting 
with DNA containing exons 1 and 2 (results not shown,). Genomic 
sequences upstream  of ATG and downstream  of the  translational stop 
codon were obtained by direct BAC sequencing w ith sequence-specific 
primers.
Chromosomal Localization—The chromosomal location of the  hum an 
GCAP3 gene was identified by PCR with prim ers 654 <5'-ATG GGG 
AAT GGC AAA TCT ATAG,) and 655 <5'-CGT GTC AAA GGT ATT ATA 
AAC TTGJ using hum an-ham ster somatic cell hybrids (BIOS Labora­
tories,) as tem plates. The PCR amplification was performed as described 
previously (24,). For subchromosomal localization, the  GCAP3 cDNA 
probe was labeled w ith biotin-14-dATP using the  BioNick labeling 
system (Life Technologies,). The probe was hybridized to prom etaphase 
chromosomes prepared from chromosomal norm al peripheral blood 
lymphocytes obtained by standard  clinical laboratory techniques. Flu­
orescence in situ  hybridization (FISH,) was performed as described 
previously (24,) w ith some modifications. Pretreatm ent was performed 
with 0.1 fig/ml proteinase K (Sigma,) in 0.3 M NaCl, 0.03 M sodium 
citrate  (2x SSC,). The probe (200 ng,) was combined w ith Cot-1 DNA, 
precipitated with ethanol, and hybridized to m etaphase chromosomes 
for 72 h. Postwashing was done a t 45 °C with a  5-min incubation in  50% 
formamide, 2 x  SSC followed by a  2-min rinse in 2x  SSC and PBS. The 
labeled probe was detected after two layers of avidin-fluorescein (ON- 
COR, Gaithersburg, MD,). Slides were counterstained with 4',6-dia- 
midino-2-phenylindole (Vysis, Downer’s Grove, IL,) diluted 1:1 with 
antifade (Vectashield, Vector, Burlingame, CA,). Hybridized G band-like 
m etaphase cells were obtained and viewed using the  M-FISH version 
3.012 software program  in the VYSIS QUIPS Imaging system.
RESULTS
Cloning o f GCAPS cDNA—An expressed sequence tag  (Gen­
Bank™ accession num ber AA364442) with homology to GCAPs 
was found by searching data  bases w ith GCAP2 sequence using 
the TFASTA program (GCG Package). Prim ers designed within 
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F ig. 4. S o u th e rn  b lo ts  o f  v a r io u s  
v e r t e b r a t e s  a n d  i n v e r t e b r a t e s  
p ro b e d  w ith  GCAP3 cDNA. A, EcoRI 
digests of genomic DNA from t t  mamma­
lian species. B, EcoRI digests of three 
m am m alian DNAs, th ree  ve rteb ra tes , 
three  invertebrates, yeast, and E. coli 
Size m arkers are indicated on the  left. 
Fragm ents containing coding sequences 
of the  hum an GCAP3 gene are identified 
on the right.
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3'-ends of GCAP3 in two overlapping fragm ents by PCR em­
ploying a hum an re tina  cDNA library. A contiguous cDNA 
comprising the complete coding sequence, suitable for expres­
sion, was amplified using N- and C-term inal primers. The first 
ATG present on the cDNA matched the Kozak consensus se­
quence (25) for initiation of translation w ith a G residue fol­
lowing the ATG and a purine, preferably A, th ree nucleotides 
upstream  (Fig. 3). The cDNA encodes a  protein of 209 amino 
acids w ith a calculated molecular m ass of 23.8 kDa (Fig. 1). The 
sequence shows a putative site for iV-myristoylation a t Gly2 
and three putative EF hands involved in Ca2+ binding. The 
amino acid sequence of GCAP3 shares closest homology with 
the hum an GCAPl, displaying 58% sim ilarity and 45% se­
quence identity (Fig. 1, dendrogram). GCAP3 is an acidic pro­
tein  w ith an isoelectric point of 4.8. This value is sim ilar to 
those calculated for GCAPl (pKa = 4.1) and GCAP2 (pKa = 
4.5).
Splice Variants—PCR amplification of GCAP3 and screening 
of a hum an re tina  cDNA library yielded normal GCAP3 cDNA 
clones and also two distinct variants, which have retained 40 
base pairs of intron c (Fig. 3). One varian t carried a G - > T  
transition  a t the first base of intron c, abolishing the exon/ 
intron junction consensus sequence (Fig. 3). Conceptual tran s­
lation of these varian ts predicts 196-residue polypeptides, 
which, if produced, would have a C-term inal domain distinct 
from other GCAPs. The fourth EF-hand m otif would be in part 
deleted and rendered nonfunctional. The 49-amino acid-long 
sequence specific for the splice varian ts has 61% sequence 
sim ilarity over a stretch  of 31 residues w ith hum an calbindin, 
a  SlOO-like Ca2+-binding protein (26, 27). I t is unclear w hether 
these varian ts  would have GC-stim ulating activity, since the 
C-terminal region of GCAPl is necessary for its interaction 
w ith GC (28), and the truncation of the C term inus in  the 
GCAP3 varian t may lead to inactivation. Prelim inary quanti­
tative PCR using specific prim ers suggested th a t the cDNA 
encoding GCAP3 m ay be less abundant than  the splice varian t 
(data not shown).
Tissue Distribution o f GCAPS Expression—The expression of 
GCAP3 was tested in different hum an tissues by N orthern blot 
analysis (Fig. 2). A single mRNA of 1.3 kb was detected pri­
m arily in  hum an retina. A low intensity  band of the same 
mobility was detectable in  skeletal muscle, but no attem pt has 
been made to verify its identity. U sing hum an GCAP3 cDNA as 
a probe, a GCAP3 ortholog was not detectable in bovine (Fig. 2) 
and mouse retina (data not shown), suggesting low levels of 
expression or a low degree of sequence conservation.
Gene Structure o f GCAPS—A hum an BAC genomic DNA 
library was screened w ith the full-length GCAP3 cDNA probe 
(Genome Systems, Inc.) and two positive clones were obtained. 
One of the BAC clones was used for direct sequencing to deter­
mine the positions of the intron and exon splice junctions. The 
GCAP3 gene (Fig. 3A) consists of four exons and th ree introns 
localized a t the same positions as those of GCAPl and GCAP2 
genes. The lengths of the GCAP3 introns are larger, and the 
intron sequences show no sequence sim ilarity w ith correspond­
ing introns of the GCAPl and GCAP2 genes (Fig. 3C). The 
GCAP3 gene encompasses more than  25 kb of genomic DNA, 
while the GCAP1/GCAP2 gene array  is contained in less than  
20 kb. The identical gene structure of the GCAP genes suggests 
th a t they were generated by gene duplication from a common 
ancestral gene.
Chromosomal Localiza tion o f the GCAP3 Gene—Amplifica­
tion of a portion of exon 1 of the GCAP3 gene w ith prim ers 654 
and 655 (Fig. 3A) from hum an-ham ster somatic hybrid panels 
located the gene to chromosome 3. The GCAP3 gene localiza­
tion was fu rther analyzed by FISH using a GCAP3 cDNA 
probe, which fine-mapped the gene to 3ql3.1 on banded m et­
aphase chromosomes (Fig. 3D). The locus of the GCAP3 gene on 
chromosome 3, a t band ql3.1, is different from the loci of 
GCAPl and GCAP2 both arranged in a tail-to-tail cluster on 
chromosome 6 (p21.1). This suggests th a t GCAP genes not only 
have been duplicated but also have been translocated to an ­
other chromosome.
Southern Blot Analysis—The presence of the GCAP3 gene in 
diverse species was analyzed by genomic Southern blotting 
under stringent hybridization conditions. A signal, distinct 
from those observed w ith GCAPl and GCAP2 genes, was de­
tected in tam arin, hum an, pig, cat, chicken, cow, sheep, and 
dog, but not in rodents. U nder the hybridization conditions, the 
GCAP3 gene was not detectable in amphibians, fish, inverte­
brates, and prokaryotes (Fig. 4). The results suggest th a t the 
GCAP3 gene sequence is well conserved only in some of the 
higher vertebrates.
Activity o f GCAP3 Expressed in  Insect Cells—GCAP3 was 
expressed in  insect cells, purified by affinity chromatography, 
and assayed for stim ulation of GC. GCAP3 was partially  my- 
ristoylated (>75%, data  not shown) as determ ined using 
[3H]Leu and [3H]myristic acid (28). M yristoylation of GCAP3 
was not absolutely required for activity, since unm yristoylated 
GCAP3 expressed in E. coli had approximately 50% of the 
specific activity of GCAP3 expressed in insect cells. In contrast, 






















F ig. 5. S tim u la tio n  o f  GC a c tiv ity  b y  GCAP3. A, Ca2+ t i t r a t i o n  o f GC a c t iv ity  in w a sh e d  ROS m e m b ra n e s  in t h e  p re s e n c e  o f  4 ;ng o f  GCAP3 
o r  G CA Pl. For GCAPl, IC50 = 240 ± 42 nM LCaz+Jfree; fo r  GCAP3, IC50 = 254 ± 48 nM lCa2+Jfree. Inset, d o se  d e p e n d e n c e  o f  GC a c t iv ity  in w a sh e d  
ROS b y  GCAPl (EC50 =  0.7 ± 0.2 f iM )  a n d  GCAP3 (EC50 =  0.6 ± 0.2 B, Ca2+ t i t r a t i o n  o f  GC1 a c t iv ity  in in s e c t  cell m e m b ra n e s  in t h e  p re s e n c e  
o f  4 n g  o f  GCAP3 o r GCA Pl. For GCAPl, IC50 =  180 ± 35 nM [Ca2+Jfree; fo r  GCAP3, IC50 =  204 ± 42 nM lCa2+Jfree. Inset, d o se  d e p e n d e n c e  o f GC1 
a c t iv ity  in in s e c t  ce lls  m e m b ra n e s  b y  GCAPl (EC50 =  0.8 ± 0 .1  f iM )  a n d  GCAP3 (EC50 =  1.0 ±  0.2 C, in h ib itio n  o f  GC s tim u la t io n  b y  GCAPl 
t r ip le  m u ta n t .  GC in w a sh e d  ROS w a s  s t im u la te d  b y  1.5 jim GCAPl (E75D,El 11D,E155D) m u ta n t  a t  [Ca2 | lv.„, =  2 /.iM in th e  p re s e n c e  o f  v a r io u s  
concentrations o f  GCAPl (IC50 =  0.7 ±  0.1 n m) and GCAP3 (IC50 =  0.6 ±  0.1 n m). • ,  bovine GCAPl; ■ , hum an GCAP3
—20% as active as the native GCAPs, respectively.
A t low [Ca2"], GCAP3 stim ulated photoreceptor GC in 
washed ROS and in recom binant GC1 w ith sim ilar affinity and 
efficiency (Fig. 5, A  and B, insets) and displayed Ca2" sensitiv­
ity comparable with GCAPl (Fig. 5, A and B). To te st if  GCAP3 
and GCAPl in teract w ith the same site on GC1, competi­
tio n  assay s w ere done w ith  a c o n s titu tiv e ly  active 
GCAP1(E75D,E111D,E155D) triple m utant. This m u tan t does 
not bind Ca2" and thus activates GC a t high [Ca2"]free (28). 
Sim ilar am ounts of GCAPl and GCAP3 competed w ith the 
triple m u tan t (Fig. 5 0 ,  suggesting th a t the binding sites for 
both proteins are a t least partially  overlapping. Inhibition of 
the basal activity of GC was also observed w ith GCAP3. 
GCAPl, GCAP2, and GCAP3 stim ulated recom binant GC1 
(Fig. 6, A, C, and E), while only GCAP2 and GCAP3 were 
capable of significant stim ulation of GC2 (Fig. 6, B, D, and F).
Specificity o f Anti-G CAP Antibodies—To avoid cross-reactiv­
ity  between anti-GCAP antibodies, each anti-GCAP serum  was 
depleted of contam inating IgGs by affinity chromatography
and subsequently individually purified using the original an ti­
gen as affinity m atrix. W estern and enzyme-linked immunosor­
bent assays were used to test the specificity of purified anti- 
GCAPl (UW14), anti-GCAP2 (UW50), and anti-GCAP3 
(UW84) (see “M aterials and Methods”). In addition, anti-pep­
tide antibody UW87, specific to the unique C term inus of 
GCAP3, was obtained. On W estern blot, all antibodies were 
monospecific (Fig. 7A). The binding of anti-GCAPl antibody 
UW14 to GCAPl-coated plates was competed only by GCAPl 
and not by GCAP2 and GCAP3 in a m olar range of dilution 
1:1000 (Fig. 7B). The two other antibodies were also completely 
specific, UW50 to GCAP2 and UW84 to GCAP3. These antibod­
ies were used to verify the level of expression of GCAPl, 
GCAP2, and GCAP3 in hum an and bovine retina (Fig. 7 0 .  
GCAPl and GCAP2 were readily detectable in both tissues, 
while GCAP3 was not detected by UW84 under W estern 
conditions sim ilar to those used w ith  UW14 and UW50 (Fig. 
7 0 .  Longer exposure of the  blot to the  alkaline phosphatase 
















Regulation o f Guanylyl Cyclase 









Fig. 6. S tim u la tio n  o f  GC1 a n d  GC2 
by G C A Pl, GCAP2, a n d  GCAP3. Dose 
dependence of bovine GC1 (b G C l) and h u ­
m an GC2 (hGC2) stim ulation a t low and 
high fCa2 llirm, by recom binant bovine 
GCAPl (bGCAPl; A  and B ). recom binant 
bovine GCAP2 (bGCAP2; C and D), and 
recom binant hum an GCAP3 (HGCAP3; E  
and F). 50% of maximal stim ulation was 
observed for the  following pairs: GCAPl/ 
GC1. 0.8 ± 0.1 /j,m; GCAP1/GC2. not 
measurable; GCAP2/GC1. 0.3 ± 0.1 /am; 
GCAP2/GC2. 0.5 ± 0.2 /am; GCAP3/GC1. 
1.0 ± 0.2 /XM; and GCAP3/GC2. 1.1 ± 0.3 
/am. O. 50 nM fCa21 l lr„ ;  B. 2 /am fCa2 1 l lroo.
tras t, UW87 readily  detected GCAP3 in hum an tissue and 
not in bovine tissue when incubated overnight w ith the blot 
(Fig. 7C).
DISCUSSION
In this paper, we describe the characterization of a new 
guanylyl cyclase-activating protein, term ed GCAP3. The 
GCAP3 protein shows high sequence sim ilarity to GCAPl 
(57%) and to a lesser degree to GCAP2 (49%) and other Ca2+- 
binding proteins (40% and 35% sim ilarity w ith recoverin and 
calmodulin, respectively ). The homology is localized mostly in 
and around the E F-hands able to bind Ca2+ (Fig. 1). All GCAPs 
are predicted to have th ree functional EF-hands for binding of 
Ca2+ and have acidic isoelectric points, sim ilar molecular 
m asses (GCAP3, 23.4 kDa; GCAPl, 22.9 kDa; GCAP2, 23.4 
kDa), and a consensus sequence for JV-myristoylation a t Gly2. 
The myristoylation of GCAP3 was confirmed by heterologous 
expression in insect cells in the presence of [3H]myristic acid. 
The precise function of the myristoylation in GCAPs is unclear,
although this modification is conserved among GCAPs and 
among related recoverins/neurocalcins (6, 29, 30).
M ultiple-tissue N orthern blot analysis revealed a single 
band of 1.3 kb abundantly  detectable only in hum an retina. The 
level of GCAP3 mRNAs in hum an re tina  w as found a t least as 
high or higher than  th a t of GCAPl and GCAP2. This was 
surprising, since GCAP3 proteins appear to be less abundant 
than GCAPl and GCAP2 as judged by W estern blots with 
monospecific antibodies (Fig. 7). This discrepancy between the 
mRNA and protein levels m ay be explained by the abundant 
transcription of mRNA encoding a  splice varian t retain ing part 
of intron c. A lternatively, the am ount of GCAP3 in the retina 
may be regulated a t a posttranscriptional level. GCAP3 mRNA 
was not detectable in bovine re tina  w ith hum an cDNA as a 
probe. A ttem pts to clone GCAP3 from bovine and mouse cDNA 
by PCR or library screening were so far unsuccessful. However, 
the bovine GCAP3 gene was detectable in Southern blot anal­






















Fig. 7. W es te rn  b lo t a n a ly s is  o f  th e  e x p re ss io n  o f  G C A Ps in  h u m a n  a n d  b o v in e  r e t in a  u s in g  sp ec ific  an ti-G C A P an tib o d ie s . A,
specificity of anti-GCAP antibodies. Anti-GCAP sera were depleted from cross-reactive IgGs and purified as described under “M aterials and 
Methods'” Lane 1. purified GCAPl (1 ng); lane 2. purified GCAP2 (1 ng); lane 3. purified GCAP3 (1 ng)- a, SDS-polyacrylamide gel stained with 
Coomassie B rilliant Blue R-250. Lane S. s tandard  proteins (94. 67. 43. 30. 20. and 14 kDa); b^d. reactivity of GCAP1/GCAP2/GCAP3 by W estern 
blot analysis (loaded as in a) w ith anti-GCAPl (UW14). anti-GCAP2 (UW50) and anti-GCAP3 (UW84). respectively. Lane S . standard  proteins 
(104. 81, 47.7. 34.6. 28.3. and 19.2 kDa). B, specificity of anti-GCAP antibodies tested by enzyme-linked immunosorbent assay, a, anti-GCAPl. 
UW14 antibody (0.45 ng) and increasing am ounts of GCAPs were added to GCAPl-coated plates. GCAP2 and GCAP3 had no effect, and for GCAPl. 
1C50 = 0.09 ± 0.02 ixg; b. anti-GCAP2 antibodies; UW50 antibodies (0.45 ng) and increasing am ounts of GCAPs were added to GCAP2-coated 
plates. GCAPl and GCAP3 had no effect, and for GCAP2.1C50 = 0.10 ± 0.02 ng; c. anti-GCAP3. UW84 antibodies (0.5 ng) and increasing am ounts 
of GCAPs were added to GCAP3-coated plates. GCAPl and GCAP2 had no effect, and for GCAP3.1C50 = 0.25 ± 0.04 ng. C. W estern blot analysis 
of the expression of GCAPs in bovine and hum an retina. H um an (.H) or bovine (B) retinal extracts ( - 8  ng each) were probed with anti-GCAPl 
(UW14), anti-GCAP2 (UW50). anti-GCAP3 (UW84). or anti-GCAP3 peptide (UW87).
signals under the same stringency (Fig. 4), suggesting the 
absence of the GCAP3 gene or lower sequence conservation 
w ithin these species.
Recently, localization of GCAPl and GCAP2 has been inves­
tigated by immunocytochemical methods in various species (15, 
21). Clear differences of the levels and cell distributions of 
GCAPs between species were observed. Since the regulation of 
GCs by GCAPs is a key step in light adaptation (desensitiza­
tion) (3), these results were not surprising, since different an ­
imals m ay evolve unique desensitization mechanism s in  con­
trolling the levels of cGMP. The apparent differences in  the 
mRNA GCAP3 levels would be consistent w ith varying levels of 
GCAPl and GCAP2 in other species. In  situ  hybridization 
results indicate th a t in hum an retina, GCAP3 mRNA is pres­
en t in the myoid region of photoreceptors.2 GCAP3 monospe­
cific antibodies suitable for immunocytochemical studies are
2 R. N. Farris and K. Palczewski. unpublished results.
currently not available. A separate study dedicated to cellular 
expression and subcellular localization of GCAP3 is currently 
under way.
The intron/exon arrangem ent of hum an GCAP3 is identical 
to th a t of the GCAP1/GCAP2 gene array. However, the GCAP3 
gene is not arranged w ithin the GCAP1/GCAP2 cluster but has 
been translocated to chromosome 3(ql3.1) (Fig. 3D). Another 
cluster of genes comprises the S-100 Ca2+-binding protein gene 
family on chromosome lq21. Some of the S-100 genes, however, 
are found also on other chromosomes (31). Thus, the chromo­
somal location of GCAPl and GCAP2 in a cluster on 6p and 
another homologous gene, GCAP3, on 3q has other precedents. 
It is interesting  to note th a t the positions of the two introns of 
the hum an recoverin gene (located on 17q) are exactly as those 
of introns b and c of the GCAP genes (Fig. 3 0 .  The close 
relationship between the GCAP and recoverin gene structure 
suggests th a t these genes were generated by gene duplication 






















with autosomal dom inant cone dystrophy, the 3ql3.1 locus has 
not yet been associated with any known retinal disease.
The th ree GCAPs in teract w ith GC1 employing overlapping 
sites, in part, because they all compete with the constitutively 
active m utan t of GCAPl. The th ree GCAPs stim ulate recom­
binant GC 1 with a sim ilar affinity and efficiency. GCAP3 and 
GCAP2 activate both GC1 and GC2, whereas GCAPl activates 
only GC1. W hat is particular to GCAP2 and GCAP3 th a t would 
account for the specific interaction with GC2? Only seven 
amino acids are identical or represent conservative substitu ­
tions (Ser6, H is38, Asn82, G in127, P ro131, He135, and He188; see 
Fig. 1) between GCAP3 and GCAP2 on one side and GCAPl on 
the other. It is known, from hybrid studies between bovine 
GCAP2 and neurocalcin (32), th a t the amino acids between 
Lys30 and Phe49, and between Asn188 and Asn189, are necessary 
for GCAP2 to activate GCs. This suggests th a t H is38 and/or 
lie188 of GCAP3 m ight be im portant for the interaction with 
GC2.
GCAP3 is the fifth Ca2+-binding protein th a t interacts with 
GC. This list includes GCAPl, GCAP2, guanylyl cyclase-inhib­
itory protein, and perhaps S1OO0 (6, 7, 8, 13, 33). These find­
ings do not come as a surprise, since Ca2+ has been postulated 
to control the ra te  of recovery to dark  condition upon illum ina­
tion and to establish the level of desensitization during light 
adaptation (3). The identification of m ultiple proteins th a t 
sense changes in [Ca2+] w ithin the cone and rod cells, including 
GCAP3 described in these studies, suggest complex regulatory 
mechanisms for controlling the activity of photoreceptor GCs.
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